NO970805L - Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme - Google Patents

Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme

Info

Publication number
NO970805L
NO970805L NO970805A NO970805A NO970805L NO 970805 L NO970805 L NO 970805L NO 970805 A NO970805 A NO 970805A NO 970805 A NO970805 A NO 970805A NO 970805 L NO970805 L NO 970805L
Authority
NO
Norway
Prior art keywords
pct
hydrolyzed collagen
tasteless
same
agent containing
Prior art date
Application number
NO970805A
Other languages
English (en)
Other versions
NO318182B1 (no
NO970805D0 (no
Inventor
Adam Milan
Bernd Eggersgluess
Klaus Brauemer
Reinhard Schrieber
Original Assignee
Dgf Stoess Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dgf Stoess Ag filed Critical Dgf Stoess Ag
Publication of NO970805L publication Critical patent/NO970805L/no
Publication of NO970805D0 publication Critical patent/NO970805D0/no
Publication of NO318182B1 publication Critical patent/NO318182B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Seasonings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
NO19970805A 1994-08-23 1997-02-21 Anvendelse av smaksnoytralt, enzymatisk, hydrolysert kollagen fra dyrisk hud og middel inneholdende samme. NO318182B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4429842 1994-08-23
PCT/EP1995/003304 WO1996005851A1 (de) 1994-08-23 1995-08-19 Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe

Publications (3)

Publication Number Publication Date
NO970805L true NO970805L (no) 1997-02-21
NO970805D0 NO970805D0 (no) 1997-02-21
NO318182B1 NO318182B1 (no) 2005-02-14

Family

ID=6526329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970805A NO318182B1 (no) 1994-08-23 1997-02-21 Anvendelse av smaksnoytralt, enzymatisk, hydrolysert kollagen fra dyrisk hud og middel inneholdende samme.

Country Status (12)

Country Link
US (1) US5948766A (no)
EP (1) EP0777491B1 (no)
JP (1) JPH10504555A (no)
AT (1) ATE282423T1 (no)
AU (1) AU703137B2 (no)
CA (1) CA2198099C (no)
DE (1) DE59510968D1 (no)
ES (1) ES2233947T3 (no)
FI (1) FI118513B (no)
NO (1) NO318182B1 (no)
PT (1) PT777491E (no)
WO (1) WO1996005851A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4609807B2 (ja) * 1996-03-28 2011-01-12 雪印乳業株式会社 骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) * 1997-06-18 1999-01-19 Zenyaku Kogyo Kk 骨粗鬆症予防・治療剤
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
JP2009148275A (ja) * 2000-08-30 2009-07-09 Morisuke Yokoyama 特定保健用食品
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
JP4766818B2 (ja) * 2002-07-24 2011-09-07 隆文 小濱 妊娠時に特異的な腰痛、股関節痛及び鼠径部痛の改善・治療剤
DE10339180A1 (de) * 2003-08-21 2005-03-24 Deutsche Gelatine-Fabriken Stoess Ag Kollagenhydrolysat
KR101361379B1 (ko) * 2005-04-13 2014-02-10 유키지루시 메그밀크 가부시키가이샤 영양 조성물
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
AU2006294581B2 (en) 2005-09-27 2011-11-03 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
ES2288791B1 (es) * 2006-02-10 2008-12-01 Masterfarm, S.L. Procedimiento de obtencion de un hidrolizado de colageno. hidrolizado enzimatico de colageno obtenible por el procedimiento y usos del mismo.
ES2298071B1 (es) * 2006-10-25 2009-07-28 Masterfarm,S.L. Hidrolizado enzimatico de colageno y procedimiento de obtencion.
US20100113368A1 (en) * 2007-03-21 2010-05-06 Luppo Edens Cholesterol lowering protein hydrolysates
JP2008231065A (ja) * 2007-03-23 2008-10-02 Chisso Corp 骨代謝改善剤
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
DE102011000997A1 (de) 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
WO2012149486A1 (en) * 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
DE102012110612A1 (de) 2012-11-06 2014-05-08 Gelita Ag Kollagenhydrolysat und dessen Verwendung
EP2948003B1 (en) 2013-01-23 2020-03-18 Bottled Science Limited Skin enhancing beverage composition
CN107847506A (zh) 2015-06-22 2018-03-27 来普卡公司 含17‑羟基孕酮酯的口服组合物和相关方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CN110691604A (zh) * 2017-03-15 2020-01-14 罗赛洛公司 水解胶原蛋白肽和共生微生物的组合物及其方法
DE102019202606A1 (de) 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102021119031A1 (de) 2021-07-22 2023-01-26 Manfred Lotz Behandlung von Polymyalgia Rheumatica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1227534A (no) * 1967-08-31 1971-04-07
CA1302880C (en) * 1986-07-25 1992-06-09 Peter Koepff Agents for the treatment of arthroses
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
CN1045719C (zh) * 1993-04-10 1999-10-20 北京市西城区华新生化技术研究所 口服接骨和治骨质疏松液
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases

Also Published As

Publication number Publication date
ATE282423T1 (de) 2004-12-15
FI970703A (fi) 1997-02-19
US5948766A (en) 1999-09-07
CA2198099A1 (en) 1996-02-29
JPH10504555A (ja) 1998-05-06
DE59510968D1 (de) 2004-12-23
FI118513B (fi) 2007-12-14
PT777491E (pt) 2005-01-31
NO318182B1 (no) 2005-02-14
EP0777491A1 (de) 1997-06-11
EP0777491B1 (de) 2004-11-17
FI970703A0 (fi) 1997-02-19
WO1996005851A1 (de) 1996-02-29
CA2198099C (en) 2001-01-16
ES2233947T3 (es) 2005-06-16
NO970805D0 (no) 1997-02-21
AU703137B2 (en) 1999-03-18
AU3347095A (en) 1996-03-14

Similar Documents

Publication Publication Date Title
NO970805L (no) Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme
ATE164061T1 (de) Magensäure-bindende kaupastillen
NO2014010I1 (no) Radium 223 salt slik som Radium 223 diklorid
PT831882E (pt) Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas
IS4100A (is) Aðferð við meðhöndlun á ígræðlingi úr málmi fyrirskurðaðgerð
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
EA199900830A1 (ru) Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья
NO971182L (no) Anvendelse av 2,4-diaminopyrimidin-3-oksyd eller et salt derav for behandling av maturasjons- og struktureringsforstyrrelser av kollagen
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.
ATE183384T1 (de) Lactulose-pastillen
NO179009C (no) Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
AU7710096A (en) A composition for odontostomatological use in cleaning and disinfecting the root canals and viable dentine
DE69626276D1 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
SE9001592L (sv) Terapeutisk komposition
DE69606627D1 (de) Pharmazeutische zusammensetzungen zur polarisationsregulierung der einheitlichen glatten muskeln
FR2700116B1 (fr) Application d'anticonvulsivants comme radioprotecteurs.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees